Metabolomics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

The global metabolomics market is expected to grow at a CAGR of around 10% during 2022-2028. This report on global metabolomics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global metabolomics market by segmenting the market based on product, indication, application, and region. Also, detailed profiles of companies operating in the metabolomics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision. 

Market Drivers

• Growing Geriatric Population
• Rising Adoption Rate of Metabolomics as a Research and Development Tool

Market Challenges

• High Cost of Metabolomic Instruments

Historical & Forecast Period

Base Year: 2021

Historical Period: 2017-2020

Forecast Period: 2022-2028

Market by Product

• Metabolomics Instruments
• Metabolomics Bioinformatics Tools and Services

Market by Indication

• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Others

Market by Application

• Biomarker and Drug Discovery
• Toxicology
• Nutrigenomics
• Personalized Medicine
• Others

Market by Region

• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
• • Saudi Arabia
  • Turkey
  • Iran
  • United Arab Emirates
  • Rest of Middle East & Africa

1. Preface
1.1. Objective
1.2. Target Audience & Key Offerings
1.3. Report’s Scope
1.4. Research Methodology
1.4.1. Phase I
1.4.2. Phase II
1.4.3. Phase III
1.5. Assumptions
2. Key Insights
3. Global Metabolomics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Metabolomics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Metabolomics Market by Product
5.1. Introduction
5.2. Metabolomics Instruments
5.3. Metabolomics Bioinformatics Tools and Services
6. Global Metabolomics Market by Indication
6.1. Introduction
6.2. Cancer
6.3. Cardiovascular Disorders
6.4. Neurological Disorders
6.5. Inborn Errors of Metabolism
6.6. Others
7. Global Metabolomics Market by Application
7.1. Introduction
7.2. Biomarker and Drug Discovery
7.3. Toxicology
7.4. Nutrigenomics
7.5. Personalized Medicine
7.6. Others
8. Global Metabolomics Market by Region
8.1. Introduction
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Russia
8.2.7. Netherlands
8.2.8. Rest of the Europe
8.3. North America
8.3.1. United States
8.3.2. Canada
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. South Korea
8.4.5. Australia
8.4.6. Indonesia
8.4.7. Rest of the Asia Pacific
8.5. Latin America
8.5.1. Mexico
8.5.2. Brazil
8.5.3. Argentina
8.5.4. Rest of Latin America
8.6. Middle East & Africa
8.6.1. Saudi Arabia
8.6.2. Turkey
8.6.3. Iran
8.6.4. United Arab Emirates
8.6.5. Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Agilent Technologies Inc.
12.2.2. Biocrates Life Sciences AG
12.2.3. Bio-Rad Laboratories Inc.
12.2.4. Bruker Corporation
12.2.5. Danaher Corporation
12.2.6. Human Metabolome Technologies Inc.
12.2.7. Metabolon Inc.
12.2.8. Shimadzu Corporation
12.2.9. Thermo Fisher Scientific Inc.
12.2.10. Waters Corporation Ltd.

List of Figures

Figure 1: Global Metabolomics Market (in US$ Million), 2017-2021
Figure 2: Global Metabolomics Market by Product, 2021
Figure 3: Global Metabolomics Market by Indication, 2021
Figure 4: Global Metabolomics Market by Application, 2021
Figure 5: Global Metabolomics Market by Region, 2021
Figure 6: Global Metabolomics Market (in US$ Million), 2022-2028
Figure 7: Global Metabolomics Market by Product (in %), 2021 & 2028
Figure 8: Global Metabolomics Instruments Market (in US$ Million), 2017-2021
Figure 9: Global Metabolomics Instruments Market (in US$ Million), 2022-2028
Figure 10: Global Metabolomics Bioinformatics Tools and Services Market (in US$ Million), 2017-2021
Figure 11: Global Metabolomics Bioinformatics Tools and Services Market (in US$ Million), 2022-2028
Figure 12: Global Metabolomics Market by Indication (in %), 2021 & 2028
Figure 13: Global Cancer Metabolomics Market (in US$ Million), 2017-2021
Figure 14: Global Cancer Metabolomics Market (in US$ Million), 2022-2028
Figure 15: Global Cardiovascular Disorders Metabolomics Market (in US$ Million), 2017-2021
Figure 16: Global Cardiovascular Disorders Metabolomics Market (in US$ Million), 2022-2028
Figure 17: Global Neurological Disorders Metabolomics Market (in US$ Million), 2017-2021
Figure 18: Global Neurological Disorders Metabolomics Market (in US$ Million), 2022-2028
Figure 19: Global Inborn Errors of Metabolism Metabolomics Market (in US$ Million), 2017-2021
Figure 20: Global Inborn Errors of Metabolism Metabolomics Market (in US$ Million), 2022-2028
Figure 21: Global Other Products Metabolomics Market (in US$ Million), 2017-2021
Figure 22: Global Other Products Metabolomics Market (in US$ Million), 2022-2028
Figure 23: Global Metabolomics Market by Application (in %), 2021 & 2028
Figure 24: Global Biomarker and Drug Discovery Metabolomics Market (in US$ Million), 2017-2021
Figure 25: Global Biomarker and Drug Discovery Metabolomics Market (in US$ Million), 2022-2028
Figure 26: Global Toxicology Metabolomics Market (in US$ Million), 2017-2021
Figure 27: Global Toxicology Metabolomics Market (in US$ Million), 2022-2028
Figure 28: Global Nutrigenomics Metabolomics Market (in US$ Million), 2017-2021
Figure 29: Global Nutrigenomics Metabolomics Market (in US$ Million), 2022-2028
Figure 30: Global Personalized Medicine Metabolomics Market (in US$ Million), 2017-2021
Figure 31: Global Personalized Medicine Metabolomics Market (in US$ Million), 2022-2028
Figure 32: Global Other Applications Metabolomics Market (in US$ Million), 2017-2021
Figure 33: Global Other Applications Metabolomics Market (in US$ Million), 2022-2028
Figure 34: Global Metabolomics Market by Region (in %), 2021 & 2028
Figure 35: Europe Metabolomics Market (in US$ Million), 2017-2021
Figure 36: Europe Metabolomics Market (in US$ Million), 2022-2028
Figure 37: Europe Metabolomics Market by Country (in %), 2021 & 2028
Figure 38: Germany Metabolomics Market (in US$ Million), 2017-2028
Figure 39: United Kingdom Metabolomics Market (in US$ Million), 2017-2028
Figure 40: France Metabolomics Market (in US$ Million), 2017-2028
Figure 41: Italy Metabolomics Market (in US$ Million), 2017-2028
Figure 42: Spain Metabolomics Market (in US$ Million), 2017-2028
Figure 43: Russia Metabolomics Market (in US$ Million), 2017-2028
Figure 44: Netherlands Metabolomics Market (in US$ Million), 2017-2028
Figure 45: North America Metabolomics Market (in US$ Million), 2017-2021
Figure 46: North America Metabolomics Market (in US$ Million), 2022-2028
Figure 47: North America Metabolomics Market by Country (in %), 2021 & 2028
Figure 48: United States Metabolomics Market (in US$ Million), 2017-2028
Figure 49: Canada Metabolomics Market (in US$ Million), 2017-2028
Figure 50: Asia Pacific Metabolomics Market (in US$ Million), 2017-2021
Figure 51: Asia Pacific Metabolomics Market (in US$ Million), 2022-2028
Figure 52: Asia Pacific Metabolomics Market by Country (in %), 2021 & 2028
Figure 53: China Metabolomics Market (in US$ Million), 2017-2028
Figure 54: Japan Metabolomics Market (in US$ Million), 2017-2028
Figure 55: India Metabolomics Market (in US$ Million), 2017-2028
Figure 56: South Korea Metabolomics Market (in US$ Million), 2017-2028
Figure 57: Australia Metabolomics Market (in US$ Million), 2017-2028
Figure 58: Indonesia Metabolomics Market (in US$ Million), 2017-2028
Figure 59: Latin America Metabolomics Market (in US$ Million), 2017-2021
Figure 60: Latin America Metabolomics Market (in US$ Million), 2022-2028
Figure 61: Latin America Metabolomics Market by Country (in %), 2021 & 2028
Figure 62: Mexico Metabolomics Market (in US$ Million), 2017-2028
Figure 63: Brazil Metabolomics Market (in US$ Million), 2017-2028
Figure 64: Argentina Metabolomics Market (in US$ Million), 2017-2028
Figure 65: Middle East & Africa Metabolomics Market (in US$ Million), 2017-2021
Figure 66: Middle East & Africa Metabolomics Market (in US$ Million), 2022-2028
Figure 67: Middle East & Africa Metabolomics Market by Country (in %), 2021 & 2028
Figure 68: Saudi Arabia Metabolomics Market (in US$ Million), 2017-2028
Figure 69: Turkey Metabolomics Market (in US$ Million), 2017-2028
Figure 70: Iran Metabolomics Market (in US$ Million), 2017-2028
Figure 71: UAE Metabolomics Market (in US$ Million), 2017-2028
Figure 72: Market Value Chain

List of Tables

Table 1: Global Metabolomics Market Portraiture
Table 2: Global Metabolomics Market by Product (in US$ Million), 2021 & 2028
Table 3: Global Metabolomics Market by Indication (in US$ Million), 2021 & 2028
Table 4: Global Metabolomics Market by Application (in US$ Million), 2021 & 2028
Table 5: Global Metabolomics Market by Region (in US$ Million), 2021 & 2028
Table 6: Europe Metabolomics Market by Country (in US$ Million), 2021 & 2028
Table 7: North America Metabolomics Market by Country (in US$ Million), 2021 & 2028
Table 8: Asia Pacific Metabolomics Market by Country (in US$ Million), 2021 & 2028
Table 9: Latin America Metabolomics Market by Country (in US$ Million), 2021 & 2028
Table 10: Middle East & Africa Metabolomics Market by Country (in US$ Million), 2021 & 2028
Table 11: List of Key Players